Alex B Munster1, Angelo J Franchini1, Mahim I Qureshi1, Ankur Thapar1, Alun H Davies2. 1. From the Academic Section of Vascular Surgery (A.B.M., M.I.Q., A.T., A.H.D.), Imperial College London; and the Department of Non-communicable Disease Epidemiology (A.J.F.), London School of Hygiene and Tropical Medicine, UK. 2. From the Academic Section of Vascular Surgery (A.B.M., M.I.Q., A.T., A.H.D.), Imperial College London; and the Department of Non-communicable Disease Epidemiology (A.J.F.), London School of Hygiene and Tropical Medicine, UK. a.h.davies@imperial.ac.uk.
Abstract
OBJECTIVE: To systematically review temporal changes in perioperative safety of carotid endarterectomy (CEA) in asymptomatic individuals in trial and registry studies. METHODS: The MEDLINE and EMBASE databases were searched using the terms "carotid" and "endarterectomy" and "asymptomatic" from 1947 to August 23, 2014. Articles dealing with 50%-99% stenosis in asymptomatic individuals were included and low-volume studies were excluded. The primary endpoint was 30-day stroke or death and the secondary endpoint was 30-day all-cause mortality. Statistical analysis was performed using random-effects meta-regression for registry data and for trial data graphical interpretation alone was used. RESULTS: Six trials (n = 4,431 procedures) and 47 community registries (n = 204,622 procedures) reported data between 1983 and 2013. Registry data showed a significant decrease in postoperative stroke or death incidence over the period 1991-2010, equivalent to a 6% average proportional annual reduction (95% credible interval [CrI] 4%-7%; p < 0.001). Considering postoperative all-cause mortality, registry data showed a significant 5% average proportional annual reduction (95% CrI 3%-9%; p < 0.001). Trial data showed a similar visual trend. CONCLUSIONS: CEA is safer than ever before and high-volume registry results closely mirror the results of trials. New benchmarks for CEA are a stroke or death risk of 1.2% and a mortality risk of 0.4%. This information will prove useful for quality improvement programs, for health care funders, and for those re-examining the long-term benefits of asymptomatic revascularization in future trials.
OBJECTIVE: To systematically review temporal changes in perioperative safety of carotid endarterectomy (CEA) in asymptomatic individuals in trial and registry studies. METHODS: The MEDLINE and EMBASE databases were searched using the terms "carotid" and "endarterectomy" and "asymptomatic" from 1947 to August 23, 2014. Articles dealing with 50%-99% stenosis in asymptomatic individuals were included and low-volume studies were excluded. The primary endpoint was 30-day stroke or death and the secondary endpoint was 30-day all-cause mortality. Statistical analysis was performed using random-effects meta-regression for registry data and for trial data graphical interpretation alone was used. RESULTS: Six trials (n = 4,431 procedures) and 47 community registries (n = 204,622 procedures) reported data between 1983 and 2013. Registry data showed a significant decrease in postoperative stroke or death incidence over the period 1991-2010, equivalent to a 6% average proportional annual reduction (95% credible interval [CrI] 4%-7%; p < 0.001). Considering postoperative all-cause mortality, registry data showed a significant 5% average proportional annual reduction (95% CrI 3%-9%; p < 0.001). Trial data showed a similar visual trend. CONCLUSIONS: CEA is safer than ever before and high-volume registry results closely mirror the results of trials. New benchmarks for CEA are a stroke or death risk of 1.2% and a mortality risk of 0.4%. This information will prove useful for quality improvement programs, for health care funders, and for those re-examining the long-term benefits of asymptomatic revascularization in future trials.
Authors: T F Kresowik; D Bratzler; H R Karp; R A Hemann; M E Hendel; S L Grund; M Brenton; E F Ellerbeck; D S Nilasena Journal: J Vasc Surg Date: 2001-02 Impact factor: 4.268
Authors: J Max Findlay; Linda Nykolyn; Tracey B Lubkey; John H Wong; Mikael Mouradian; Ambikaipakan Senthilselvan Journal: Can J Neurol Sci Date: 2002-11 Impact factor: 2.104
Authors: William H Brooks; Rick R McClure; Michael R Jones; Timothy L Coleman; Linda Breathitt Journal: Neurosurgery Date: 2004-02 Impact factor: 4.654
Authors: J D Kakisis; E D Avgerinos; C N Antonopoulos; T G Giannakopoulos; K Moulakakis; C D Liapis Journal: Eur J Vasc Endovasc Surg Date: 2012-06-01 Impact factor: 7.069
Authors: Ronnie D Horner; Eugene Z Oddone; Karen M Stechuchak; Steven C Grambow; John Gray; Shukri F Khuri; William G Henderson; Jennifer Daley Journal: Med Care Date: 2002-01 Impact factor: 2.983
Authors: Prateek K Gupta; Bala Ramanan; Jason N Mactaggart; Abhishek Sundaram; Xiang Fang; Himani Gupta; Jason M Johanning; Iraklis I Pipinos Journal: J Vasc Surg Date: 2012-11-15 Impact factor: 4.268
Authors: David A Payne; Chris I Jones; Paul D Hayes; Matthew M Thompson; Nicholas J London; Peter R Bell; Alison H Goodall; A Ross Naylor Journal: Circulation Date: 2004-03-08 Impact factor: 29.690
Authors: Jay S Yadav; Mark H Wholey; Richard E Kuntz; Pierre Fayad; Barry T Katzen; Gregory J Mishkel; Tanvir K Bajwa; Patrick Whitlow; Neil E Strickman; Michael R Jaff; Jeffrey J Popma; David B Snead; Donald E Cutlip; Brian G Firth; Kenneth Ouriel Journal: N Engl J Med Date: 2004-10-07 Impact factor: 91.245
Authors: Mandy D Müller; Stefanie von Felten; Ale Algra; Jean-Pierre Becquemin; Richard Bulbulia; David Calvet; Hans-Henning Eckstein; Gustav Fraedrich; Alison Halliday; Jeroen Hendrikse; George Howard; John Gregson; Olav Jansen; Martin M Brown; Jean-Louis Mas; Thomas G Brott; Peter A Ringleb; Leo H Bonati Journal: Circ Cardiovasc Interv Date: 2019-08-05 Impact factor: 6.546
Authors: Judith H Lichtman; Michael R Jones; Erica C Leifheit; Alice J Sheffet; George Howard; Brajesh K Lal; Virginia J Howard; Yun Wang; Jeptha Curtis; Thomas G Brott Journal: JAMA Date: 2017-09-19 Impact factor: 56.272
Authors: L Saba; W Brinjikji; J D Spence; M Wintermark; M Castillo; G J de Borst; Q Yang; C Yuan; A Buckler; M Edjlali; T Saam; D Saloner; B K Lal; D Capodanno; J Sun; N Balu; R Naylor; A V D Lugt; B A Wasserman; M E Kooi; J Wardlaw; J Gillard; G Lanzino; U Hedin; D Mikulis; A Gupta; J K DeMarco; C Hess; J V Goethem; T Hatsukami; P Rothwell; M M Brown; A R Moody Journal: AJNR Am J Neuroradiol Date: 2021-07-29 Impact factor: 4.966